Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.

Moon SJ, Park JS, Jeong JH, Yang EJ, Park MK, Kim EK, Park SH, Kim HY, Cho ML, Min JK.

Arch Pharm Res. 2013 Jan;36(1):116-24. doi: 10.1007/s12272-013-0010-0.

PMID:
23338062
2.

Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes.

Moon SJ, Woo YJ, Jeong JH, Park MK, Oh HJ, Park JS, Kim EK, Cho ML, Park SH, Kim HY, Min JK.

Osteoarthritis Cartilage. 2012 Nov;20(11):1426-38. doi: 10.1016/j.joca.2012.08.002. Epub 2012 Aug 10.

3.

The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group.

Hasegawa M, Horiki N, Tanaka K, Wakabayashi H, Tano S, Katsurahara M, Uchida A, Takei Y, Sudo A.

Mod Rheumatol. 2013 Nov;23(6):1172-8. doi: 10.1007/s10165-012-0819-2. Epub 2013 Jan 10.

PMID:
23306427
4.

Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis.

Izawa T, Mori H, Shinohara T, Mino-Oka A, Hutami IR, Iwasa A, Tanaka E.

PLoS One. 2016 Apr 28;11(4):e0154107. doi: 10.1371/journal.pone.0154107. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0162032.

5.

Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines.

Lee J, Hong YS, Jeong JH, Yang EJ, Jhun JY, Park MK, Jung YO, Min JK, Kim HY, Park SH, Cho ML.

PLoS One. 2013 Jul 22;8(7):e69362. doi: 10.1371/journal.pone.0069362. Print 2013.

6.

Efficacy of intra-articular injection of celecoxib in a rabbit model of osteoarthritis.

Jiang D, Zou J, Huang L, Shi Q, Zhu X, Wang G, Yang H.

Int J Mol Sci. 2010 Oct 21;11(10):4106-13. doi: 10.3390/ijms11104106.

7.

Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats.

Ashkavand Z, Malekinejad H, Amniattalab A, Rezaei-Golmisheh A, Vishwanath BS.

Phytomedicine. 2012 Oct 15;19(13):1200-5. doi: 10.1016/j.phymed.2012.07.008. Epub 2012 Aug 25.

PMID:
22925727
8.

Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice.

Fukai A, Kamekura S, Chikazu D, Nakagawa T, Hirata M, Saito T, Hosaka Y, Ikeda T, Nakamura K, Chung UI, Kawaguchi H.

Arthritis Rheum. 2012 Jan;64(1):198-203. doi: 10.1002/art.33324.

9.

Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes.

Jeong JH, Moon SJ, Jhun JY, Yang EJ, Cho ML, Min JK.

PLoS One. 2015 Jun 17;10(6):e0130882. doi: 10.1371/journal.pone.0130882. eCollection 2015.

10.

Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.

Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, Lafeber FP.

Rheumatology (Oxford). 2006 Apr;45(4):405-13. Epub 2005 Nov 15.

PMID:
16287921
11.

Ursodeoxycholic Acid ameliorates pain severity and cartilage degeneration in monosodium iodoacetate-induced osteoarthritis in rats.

Moon SJ, Jeong JH, Jhun JY, Yang EJ, Min JK, Choi JY, Cho ML.

Immune Netw. 2014 Feb;14(1):45-53. doi: 10.4110/in.2014.14.1.45. Epub 2014 Feb 21.

12.

Effect of alcoholic extract of Entada pursaetha DC on monosodium iodoacetate-induced osteoarthritis pain in rats.

Kumari RR, More AS, Gupta G, Lingaraju MC, Balaganur V, Kumar P, Kumar D, Sharma AK, Mishra SK, Tandan SK.

Indian J Med Res. 2015 Apr;141(4):454-62. doi: 10.4103/0971-5916.159296.

13.
14.

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis.

Zweers MC, de Boer TN, van Roon J, Bijlsma JW, Lafeber FP, Mastbergen SC.

Arthritis Res Ther. 2011;13(5):239. doi: 10.1186/ar3437. Epub 2011 Sep 21. Review.

15.

Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model.

Dong J, Jiang D, Wang Z, Wu G, Miao L, Huang L.

Int J Pharm. 2013 Jan 30;441(1-2):285-90. doi: 10.1016/j.ijpharm.2012.11.031. Epub 2012 Nov 27.

PMID:
23194887
16.

Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats.

Wang ZM, Chen YC, Wang DP.

Biomed Pharmacother. 2016 Oct;83:763-770. doi: 10.1016/j.biopha.2016.06.050. Epub 2016 Jul 30.

PMID:
27484345
17.

A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.

Brereton N, Pennington B, Ekelund M, Akehurst R.

J Med Econ. 2014 Sep;17(9):677-84. doi: 10.3111/13696998.2014.933111. Epub 2014 Jun 30.

PMID:
24914585
18.

Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.

Ishihara T, Tanaka K, Tashiro S, Yoshida K, Mizushima T.

Biochem Pharmacol. 2010 Jun 1;79(11):1622-33. doi: 10.1016/j.bcp.2010.01.030. Epub 2010 Feb 2.

PMID:
20132796
19.

A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.

Park YG, Ha CW, Han CD, Bin SI, Kim HC, Jung YB, Lim HC.

J Ethnopharmacol. 2013 Oct 7;149(3):816-24. doi: 10.1016/j.jep.2013.08.008. Epub 2013 Aug 14.

PMID:
23954277
20.

Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.

Mastbergen SC, Bijlsma JW, Lafeber FP.

Osteoarthritis Cartilage. 2005 Jun;13(6):519-26.

Supplemental Content

Support Center